MyFinsight
Home
Blog
About
Contact
Download
Download image
Accounts receivable
-$104,502K
Adjustment for excess and
obsolete inventories
-$6,990K
Amortization and write-down
of intangible...
$5,708K
Depreciation and
amortization
$4,174K
Stock-based compensation
$3,636K
Reduction in the carrying
value of right-of-use...
$2,488K
Other liabilities
$293K
Non-cash interest
expense
$91K
Net cash provided by
(used in) operating...
$21,127K
Canceled cashflow
$106,755K
Change in cash, cash
equivalents and restricted...
-$2,232K
Canceled cashflow
$21,127K
Net loss
-$53,156K
Accrued expenses and
other current...
-$19,481K
Deferred tax benefit
-$15,371K
Inventories
$8,730K
Provision recorded for
credit losses
-$3,959K
Operating leases
$2,400K
Accounts payable
-$2,003K
Prepaid expenses and
other current assets...
$1,655K
Net cash used in
financing activities
-$20,213K
Net cash used in
investing activities
-$3,146K
Principal repayments of
finance lease...
$9,840K
Landlord assets under
construction, net of tenant...
$7,322K
Payments of withholding
taxes in connection...
$3,051K
Purchases of property and
equipment
$3,146K
Back
Back
Cash Flow
source: myfinsight.com
Organogenesis Holdings Inc. (ORGO)
Organogenesis Holdings Inc. (ORGO)